STAT+: Cambrian’s experimental longevity drug mimics exercise

STAT PlusNewsletterThe Readout Cambrian’s experimental longevity drug mimics exercise What Soon-Shiong has delivered, Encanta’s RSV antiviral, and other biotech news from The Readout Manage alerts for this article Email this article Share this article By Meghana KeshavanJune 18, 2026 Biotech Correspondent Meghana Keshavan[email protected]Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Washington’s vaccine wars are escalating again as Senate Democrats seek to build a paper trail around Health Secretary Robert F. Kennedy Jr.’s controversial overhaul of the CDC’s vaccine advisory committee.Advertisement Also, Enanta’s pushing forward with its RSV antiviral, we take a critical look at Patrick Soon-Shiong’s pancreatic cancer claims, and some news from longevity player Cambria. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In biotechnology, drug development, Drug prices, research Submit a correction requestReprints Meghana Keshavan Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter. Newsletter Your morning rundown of the science, politics, and money driving biotech today Recommended Adam's Biotech Scorecard June 18, 2026 STAT Plus: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept STATus Report June 18, 2026 What’s next for GLP-1 weight loss drugs? Advertisement The Readout June 17, 2026 STAT Plus: FDA appears open to Moderna’s flu vaccine ahead of adcomm Biotech June 17, 2026 STAT Plus: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval Biotech June 17, 2026 STAT Plus: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry Subscriber Picks